Stockreport

JPMorgan Lowers PT on Immunovant (IMVT) to $33 From $37 [Yahoo! Finance]

Immunovant, Inc.  (IMVT) 
PDF lowered the firm's price target on Immunovant, Inc. (NASDAQ:IMVT) to $33 from $37 while keeping an Overweight rating on the shares. Is Immunovant, Inc. (IMVT) The Most [Read more]